Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 4Seizures 3Lennox Gastaut Syndrome 3Epilepsies, Myoclonic 3Anxiety Disorders 2Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Spasms, Infantile 1Prostatic Neoplasms 1Parasomnias 1Pain 1Neoplasms 1Nausea 1Marijuana Abuse 1Liver Cirrhosis 1Glioblastoma 1Epilepsy 1Colorectal Neoplasms 1Colonic Neoplasms 1Chemotherapy-Induced Peripheral Neuropathy 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Pain 1Breast Neoplasms 1Breast Carcinoma In Situ 1Behavior 1

Interventions

tremelimumab 1epigallocatechin gallate 1durvalumab 1babao dan 1Urination 1Standard of Care 1Rosuvastatin Calcium 1Preoperative Exercise 1Furosemide 1Erlotinib Hydrochloride 1Digoxin 1Diagnostic Imaging 1Control Groups 1Cannabidiol 1Breathing Exercises 1Breath Tests 1Blood Specimen Collection 1Aspirin 1Anti-HIV Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Cirrhosis × Cannabidiol × 1 year × Clear all
NCT05044819 2026-06-01

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Jazz Pharmaceuticals

Phase 4 Active not recruiting
154 enrolled

Epilepsies, Myoclonic, Liver Cirrhosis, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡